California Bay Area Home Health Agency, Medicare-Certified, 7-County Coverage

$2.2M

Revenue

$600K

SDE

Subscribe Free

Read the full deal writeup

Get Free Access

Already a member? Sign in

Full Editorial Writeup

This is a Medicare and Medicaid certified home health agency operating across seven California counties, including Alameda, Contra Costa, San Mateo, Stanislaus, San Joaquin, San Francisco, and Marin. The agency delivers skilled nursing, physical therapy, occupational therapy, speech therapy, and medical social work directly in patients' homes, which is the lowest-cost setting for post-acute and chronic care. It carries ACHC accreditation and a 4.5-star CMS rating, both of which are meaningful signals of clinical quality and referral credibility in a market where hospitals and physicians steer discharges based on outcomes.

The financials are clean on the surface: roughly $2.2M in annual revenue against $600K in adjusted EBITDA, a 27 percent margin that is healthy for home health. Revenue is anchored to Medicare and Medicaid reimbursement, which makes demand durable regardless of the broader economy since it tracks aging demographics and hospital discharge volume rather than discretionary spending.

The catch, and it is a big one, is that the agency is in the second stage of a Targeted Probe and Educate (TPE) audit from CMS. The seller is explicitly trying to de-risk by finding either a strategic partner or an immediate buyer, and they are screening for proof of funds and healthcare operating experience. This is not a passive buy. It is a deal for an operator who already understands home health compliance and can carry the agency through the audit without disrupting cash flow.

Why we like it

Earnings quality is solid on paper with $600K adjusted EBITDA on $2.2M revenue, a 27 percent margin that beats typical home health comps. The revenue is reimbursement-backed through Medicare and Medicaid, which means predictable payer sources rather than fickle private-pay collections, though you must verify the days-in-AR given government payment cycles.
The moat here is regulatory. ACHC accreditation, Medicare and Medicaid certification, and a 7-county Bay Area service footprint are expensive and slow to replicate, and the 4.5-star CMS rating drives referral flow from hospitals and physicians who are judged on where they discharge patients.
Demand is structurally rising. The Bay Area is aging, home health is the cheapest post-acute care setting, and payers actively push volume out of hospitals and into the home. This is about as recession-resistant as healthcare services get since utilization tracks demographics, not discretionary budgets.
For the right operator, the licensing and certification stack is a genuine barrier to entry that protects pricing and referral relationships. A buyer with an existing home health platform could bolt this on and gain instant Bay Area coverage across seven counties without building it from scratch.

How to improve it

Resolve the TPE audit first and fast. Bring in home health compliance counsel and a coding specialist to review the sampled claims, correct documentation gaps, and shepherd the agency out of the probe. Everything else is secondary until this is contained because a failed TPE can escalate to prepayment review or worse.
Rebuild the referral engine around the 4.5-star rating. Assign a liaison to work discharge planners at the top feeder hospitals across all seven counties, since a superior CMS star rating is a sales asset that most agencies underexploit in their marketing to physicians and case managers.
Optimize the payer and episode mix. Analyze margin by referral source and diagnosis, then lean into higher-acuity skilled nursing and therapy episodes that reimburse better under PDGM while trimming low-margin visits that drag clinician productivity.
Tighten clinician utilization and scheduling. Home health economics live and die on visits per clinician per day and drive time across a sprawling 7-county area. Route optimization and productivity targets can add margin without adding a single new referral.
Shore up revenue cycle management. Government payers pay slowly and reject sloppy documentation, so audit the billing workflow, reduce claim denial rates, and shorten days in AR to protect working capital through the ownership transition.
Cross-sell adjacent services within the existing patient base. With skilled nursing, PT, OT, speech, and medical social work already in house, ensure eligible patients are receiving the full appropriate care plan rather than leaving reimbursable services on the table.

Diligence notes

The TPE audit is the entire deal. Get the exact stage, the claims under review, the error rate so far, and any preliminary CMS findings. Understand the downside scenarios: continued probe, prepayment review, or extrapolated recoupment, and price the deal assuming a claw-back reserve until you know the exposure.
Verify the $600K EBITDA is truly adjusted and sustainable, not propped by the claims currently under audit. If a meaningful chunk of billed revenue could be recouped or denied, real normalized earnings may be materially lower, so tie any purchase price to post-audit cash flow.
Scrutinize payer concentration and reimbursement trends. Break revenue down by Medicare versus Medicaid versus managed care, check exposure to PDGM rate changes, and confirm the agency is not overly dependent on a single referral hospital that could disappear post-sale.
Confirm the certifications and accreditation transfer cleanly. ACHC accreditation, Medicare provider number, and state licensure handling in a change-of-ownership can trigger review periods or re-survey requirements, so map the CHOW process and timeline before closing.
Assess clinician retention and staffing. Home health quality and star ratings depend entirely on the nursing and therapy team, so review turnover, whether staff are W-2 or 1099, contractor exposure, and how many key clinicians might walk during a transition.
Pin down years in business, ownership structure, and reason for selling beyond the audit. An owner motivated to de-risk quickly can be a source of price leverage, but confirm there are no other undisclosed regulatory, licensing, or liability issues driving the urgency.

Source

Originally listed on BusinessBroker.net. View original listing →